Senseonics and Ascensia's integration enhances diabetes management through SweetSpot's software and Eversense 365 CGM system for better patient care. Senseonics Holdings, Inc. and Ascensia Diabetes ...
Israel-based DreaMed Diabetes announced this week that it has raised $3.3 million from Norma Investments, Russian businessman Roman Abramovich and one other unnamed angel. The funds will mainly be ...
WALTHAM, Mass.--(BUSINESS WIRE)--Glytec, the only provider of insulin management software across the continuum of care, today published the first proof-of-concept study that combines data from ...
The FINANCIAL — At the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) Bayer Diabetes Care announced clearance to market the CONTOUR USB meter in Europe and in the U.S ...
Paris, France-based Voluntis, a developer of companion apps for medical devices, has raised $29 million in its fourth round of funding. The round was led by Bpifrance Large Venture and international ...
Roche Diabetes Care recalled its Accu-Chek Connect diabetes management app over software issues, according to an FDA safety alert issued Feb. 15. 1. Certain iOS and Android versions of the app contain ...
GERMANTOWN, Md. and PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. and Ascensia Diabetes Care announce the software integration of SweetSpot™ with the Eversense ® 365 ...
TEL AVIV, Israel--(BUSINESS WIRE)--DreaMed Diabetes Ltd., the developer of the personalized, AI- based diabetes management solution, announces a cooperation with Texas Children's Hospital by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results